Phio Pharmaceuticals Shares Tick Higher as CEO Hits the Road; Traders Eye Small Biotech
Phio Pharmaceuticals Corp. shares traded up Wednesday. The micro-cap oncology group is set to pitch its main skin-cancer program again to investors at a virtual non-deal roadshow. The stock traded at $1.095, up 1.39%, at 12:53 p.m. EDT, MarketScreener showed, citing a Cboe BZX real-time quote. Market cap stood near $12.55 million.